SCIENTIFIC TALK AMD | 11 ottobre 2022 | ore 17 Condividi:FacebookTwitterLinkedin Post navigation Effects of empagliflozin in women and men with heart failure and preserved ejection fractionRationale and design of the phase 3 development programme (ONWARDS 1–6 trials) investigating once‐weekly insulin icodec in diabetes